source
- FDA urges validation of digital health endpoints and clear missing-data plansFDA officials highlighted key practices for sponsors using digitally derived endpoints from digital health technologies. They said endpoints must be validated for the specific patient population t…
- Trump unveils pricing agreements with midsize biotech firms; Novartis halts CAR-T trial after patient deathsThe White House announced that President Trump has struck new pricing agreements with a group of midsize biotechnology companies, aiming to adjust drug costs. Novartis disclosed that it is pausing…